The city of Sugar Land, Texas, currently has 1 active clinical trials seeking participants for Ulcerative Colitis research studies.
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will have 4 periods and will last for 36 weeks.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/17/2024
Locations: Gastroenterology Associates of Texas - Denise Rodriguez, Sugar Land, Texas
Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic